Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TSNAX-DISC1 readthrough transcript (TSNAX-DISC1)
- Target
- TSNAX-DISC1
- Molecular classification
- Other (readthrough transcript)
01
Overview
The **TSNAX-DISC1 readthrough transcript** arises from a readthrough event between the TSNAX and DISC1 genes on chromosome 1q42.1. While the region has been extensively studied for genetic association with neuropsychiatric disorders, including schizophrenia and affective disorders, there is little evidence that TSNAX-DISC1 encodes a functionally active protein or that it serves as a conventional molecular target in pharmacology. Most functional data relate to the DISC1 protein, which regulates neural development, synaptic function, and is part of complex protein interaction networks influencing neuronal growth and migration[1][2]. TSNAX-DISC1 itself remains poorly characterized, with limited or no consensus on its potential as a receptor, enzyme, or therapeutic target[3].
- Other names
- TSNAX-DISC1 readthroughTSNAX-DISC1 gene region
02
Mechanism of action
None known. There is no mechanistic information available for therapeutic modulation of TSNAX-DISC1.
03
Biological functions
None clearly defined. Unlike canonical DISC1, the TSNAX-DISC1 readthrough does not have well-characterized biological functions. Most research focuses on genetic association with psychiatric traits rather than molecular signaling or regulation.
04
Disease associations
Other (neuropsychiatric association candidate). The gene region containing TSNAX-DISC1 has been studied for its potential association with disorders such as schizophrenia, bipolar disorder, and major depressive disorder, but the specific role of the readthrough variant remains unclear.
05
Safety considerations
None described. As TSNAX-DISC1 is not a therapeutic target, no safety or toxicity concerns have been defined.
06
Interacting drugs
None known. No drugs are reported to interact directly with TSNAX-DISC1 transcript or its putative protein product.
07
Biomarkers
None established.
Beyond the preview
Go deeper on TSNAX-DISC1 readthrough transcript (TSNAX-DISC1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TSNAX-DISC1 readthrough transcript (TSNAX-DISC1).